Microneedles‐Integrated Photothermal‐Based Combinational Therapeutics for Cancer Treatment
Source abstract
Abstract
ABSTRACT Photothermal therapeutics is one of the most promising approaches for cancer treatment. Photothermal therapeutics involve light interaction of photothermal agents to generate localized heat and effectively kill cancerous cells. However, photothermal treatment can lead to uncontrolled drug delivery, limited accumulation of photothermal agents at the diseased site, and unwanted accumulation in healthy organs upon intravenous administration. Hence, photothermal therapeutics have been integrated with microneedle (MN) technology for better utilization. In this approach, the MNs are loaded with a photothermal agent or a synergistic agent/drug that enables the localized delivery of such agents at a sufficient dose. Upon light irradiation, the MNs enable precise photothermal action and controlled drug release, enhancing the therapeutic efficacy. The present review highlights recent advancements in MN‐integrated photothermal cancer therapeutics. First, the design, characterization techniques, and materials used for the fabrication of MNs are discussed. Furthermore, the application of MNs in specific tumor therapeutics based on photothermal methods is discussed. Finally, the review summarizes the current challenges and future directions for microneedle‐integrated photothermal cancer therapeutics.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Advancements in Transdermal Drug Delivery · Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biomedical Instrumentation CSIR‐Central Scientific Instruments Organization Chandigarh India
Academy of Scientific and Innovative Research (AcSIR) Ghaziabad India
Department of Biotechnology University Institute of Engineering Technology (UIET) Panjab University Chandigarh India
Energy and Environment Unit Institute of Nanoscience and Technology (INST) Mohali India
Department Bio‐ and Nanotechnology Fraunhofer Institute for Ceramic Technologies and Systems IKTS Dresden Germany
References (100+)
Show source-provided references
1. Cancer Statistics, 2024
2. 10.1186/s40169‐017‐0175‐010.1186/s40169‐017‐0175‐0 ↗
3. 10.1007/s00604‐025‐07679‐910.1007/s00604‐025‐07679‐9 ↗
4. 10.1016/j.jconrel.2020.06.03210.1016/j.jconrel.2020.06.032 ↗
5. 10.1016/j.jconrel.2017.02.02810.1016/j.jconrel.2017.02.028 ↗
6. 10.1186/s12951‐021‐01080‐310.1186/s12951‐021‐01080‐3 ↗
7. 10.1021/acsnano.5b0002110.1021/acsnano.5b00021 ↗
8. 10.1016/j.pmatsci.2018.07.00510.1016/j.pmatsci.2018.07.005 ↗
9. 10.1016/j.cis.2025.10354110.1016/j.cis.2025.103541 ↗
10. 10.1021/acsanm.1c0190310.1021/acsanm.1c01903 ↗
11. 10.1007/s00604‐025‐07073‐510.1007/s00604‐025‐07073‐5 ↗
12. 10.1016/j.cej.2021.13346610.1016/j.cej.2021.133466 ↗
13. Microfabricated Microneedles: a Novel Approach to Transdermal Drug Delivery10.1021/js980042+ ↗
14. 10.1016/j.actbio.2020.12.00410.1016/j.actbio.2020.12.004 ↗
15. 10.1016/j.ijpharm.2024.12512810.1016/j.ijpharm.2024.125128 ↗
16. A Dissolvable Microneedle Platform for the Delivery of Tumor‐derived Total RNA Nanovaccines for Enhanced Tumor Immunotherapy10.1016/j.actbio.2025.04.039 ↗
17. 10.1016/j.xcrp.2023.10143010.1016/j.xcrp.2023.101430 ↗
18. Saurabh S. · 2026 · 1
19. 10.1208/s12249‐025‐03127‐210.1208/s12249‐025‐03127‐2 ↗
20. 10.26599/NR.2025.9490796310.26599/NR.2025.94907963 ↗
21. 10.1007/s11095‐010‐0169‐810.1007/s11095‐010‐0169‐8 ↗
22. 10.1002/adfm.20230818310.1002/adfm.202308183 ↗
23. Microneedle Array Patches Integrated with Nanoparticles for Therapy and Diagnosis10.1002/sstr.202000097 ↗
24. 10.1021/acsanm.1c0083210.1021/acsanm.1c00832 ↗
25. 10.1080/10717544.2023.223295010.1080/10717544.2023.2232950 ↗
26. 10.1016/j.nantod.2023.10191310.1016/j.nantod.2023.101913 ↗
27. 10.1021/acsnano.5b0504310.1021/acsnano.5b05043 ↗
28. 10.3390/polym1316281510.3390/polym13162815 ↗
29. 10.1016/j.jddst.2020.10192310.1016/j.jddst.2020.101923 ↗
30. An Overview of Microneedle Applications, Materials, and Fabrication Methods
31. 10.1016/j.jmapro.2020.02.02410.1016/j.jmapro.2020.02.024 ↗
32. Long‐acting Microneedle Formulations10.1016/j.addr.2023.115055 ↗
33. 10.1039/C6RA26759A10.1039/C6RA26759A ↗
34. 10.1016/j.jconrel.2006.11.00910.1016/j.jconrel.2006.11.009 ↗
35. 10.1016/j.jconrel.2021.09.03610.1016/j.jconrel.2021.09.036 ↗
36. 10.1002/jps.2372410.1002/jps.23724 ↗
37. 10.1016/j.matdes.2025.11493610.1016/j.matdes.2025.114936 ↗
38. 10.1016/j.ijpharm.2010.02.00710.1016/j.ijpharm.2010.02.007 ↗
39. 10.1002/jps.2343910.1002/jps.23439 ↗
40. 10.1016/j.biopha.2018.10.07810.1016/j.biopha.2018.10.078 ↗
41. 10.3390/mi1211132110.3390/mi12111321 ↗
42. P. M.Wang M. G.Cornwell andM. R.Prausnitz “Effects of Microneedle Tip Geometry on Injection and Extraction in the Skin ” inProceedings of the Second Joint 24th Annual Conference and the Annual Fall Meeting of the Biomedical Engineering Society][Engineering in Medicine and Biology(IEEE 2002) 506–507.10.1109/IEMBS.2002.1136918 ↗
43. Microneedles′ Device: Design, Fabrication, and Applications10.3390/macromol4020019 ↗
44. 10.1016/j.jconrel.2016.08.03110.1016/j.jconrel.2016.08.031 ↗
45. 10.1016/j.bioadv.2022.21316910.1016/j.bioadv.2022.213169 ↗
46. Transdermal Drug Delivery Systems: Methods for Enhancing Skin Permeability and Their Evaluation10.3390/pharmaceutics17070936 ↗
47. 10.1016/j.jddst.2023.10488310.1016/j.jddst.2023.104883 ↗
48. 10.1097/AJP.0b013e31816778f910.1097/AJP.0b013e31816778f9 ↗
49. 10.1016/j.tiv.2010.08.01210.1016/j.tiv.2010.08.012 ↗
50. 10.1016/j.jconrel.2010.08.00810.1016/j.jconrel.2010.08.008 ↗
51. 10.2174/156720181266615030412315010.2174/1567201812666150304123150 ↗
52. 3D Printing—A “Touch‐Button” Approach to Manufacture Microneedles for Transdermal Drug Delivery10.3390/pharmaceutics13070924 ↗
53. 10.3390/pharmaceutics1108039010.3390/pharmaceutics11080390 ↗
54. 10.1016/j.jddst.2022.10365310.1016/j.jddst.2022.103653 ↗
55. 10.1002/adma.20090241810.1002/adma.200902418 ↗
56. 10.1146/annurev‐chembioeng‐060816‐10151410.1146/annurev‐chembioeng‐060816‐101514 ↗
57. 10.3938/jkps.56.122310.3938/jkps.56.1223 ↗
58. 10.1016/j.jconrel.2010.07.10410.1016/j.jconrel.2010.07.104 ↗
59. 10.1016/j.biomaterials.2010.02.02210.1016/j.biomaterials.2010.02.022 ↗
60. 10.1007/s40820‐021‐00611‐910.1007/s40820‐021‐00611‐9 ↗
61. 10.1016/j.biomaterials.2007.12.04810.1016/j.biomaterials.2007.12.048 ↗
62. 10.1088/1758‐5090/ab6d3710.1088/1758‐5090/ab6d37 ↗
63. 10.1007/s40820‐021‐00611‐910.1007/s40820‐021‐00611‐9 ↗
64. 10.1016/j.ijpharm.2020.11967310.1016/j.ijpharm.2020.119673 ↗
65. Monitoring the Penetration Process of Single Microneedles with Varying Tip Diameters10.1016/j.jmbbm.2014.09.015 ↗
66. 10.1007/s13346‐021‐01045‐x10.1007/s13346‐021‐01045‐x ↗
67. 10.3390/ijms1206364810.3390/ijms12063648 ↗
68. 10.1016/j.ejpb.2016.06.02310.1016/j.ejpb.2016.06.023 ↗
69. 10.1080/10717544.2023.216573710.1080/10717544.2023.2165737 ↗
70. 10.1186/s10033‐025‐01188‐910.1186/s10033‐025‐01188‐9 ↗
71. Nair K. J. · 2016
72. 10.1016/j.addr.2012.04.00510.1016/j.addr.2012.04.005 ↗
73. 10.3390/pharmaceutics703009010.3390/pharmaceutics7030090 ↗
74. Anbazhagan G. · 2025 · 2259
75. 10.1088/0960‐1317/14/4/02110.1088/0960‐1317/14/4/021 ↗
76. 10.1088/0960‐1317/26/6/06501310.1088/0960‐1317/26/6/065013 ↗
77. 10.1109/JMEMS.2003.82029310.1109/JMEMS.2003.820293 ↗
78. 10.1063/5.000898310.1063/5.0008983 ↗
79. 10.1109/JMEMS.2013.226258710.1109/JMEMS.2013.2262587 ↗
80. 10.3389/fbioe.2020.0082710.3389/fbioe.2020.00827 ↗
81. 10.1038/s41378‐019‐0077‐y10.1038/s41378‐019‐0077‐y ↗
82. 10.1016/j.ijpharm.2023.12288810.1016/j.ijpharm.2023.122888 ↗
83. 10.1016/j.msec.2019.05.00210.1016/j.msec.2019.05.002 ↗
84. Microneedles for in Situ Tissue Regeneration10.1016/j.mtbio.2023.100579 ↗
85. 10.1007/s13346‐018‐0549‐x10.1007/s13346‐018‐0549‐x ↗
86. 10.1016/j.jddst.2019.10146410.1016/j.jddst.2019.101464 ↗
87. Microneedle Coating Techniques for Transdermal Drug Delivery10.3390/pharmaceutics7040486 ↗
88. 10.1002/adhm.20200014710.1002/adhm.202000147 ↗
89. 10.1016/j.ijbiomac.2020.12.17710.1016/j.ijbiomac.2020.12.177 ↗
90. 10.1016/j.jconrel.2022.05.04510.1016/j.jconrel.2022.05.045 ↗
91. Dissolving and Biodegradable Microneedle Technologies for Transdermal Sustained Delivery of Drug and Vaccine
92. 10.1007/s11095‐019‐2748‐710.1007/s11095‐019‐2748‐7 ↗
93. 10.3390/ph1502019010.3390/ph15020190 ↗
94. 10.1002/adhm.20180105410.1002/adhm.201801054 ↗
95. 10.1186/s12951‐023‐01815‐410.1186/s12951‐023‐01815‐4 ↗
96. Hydrogel‐Based Microneedle as a Drug Delivery System10.3390/pharmaceutics15102444 ↗
97. Hydrogel‐Forming Microneedles in the Management of Dermal Disorders Through a Non‐Invasive Process: A Review10.3390/gels10110719 ↗
98. 10.1002/mabi.20200030710.1002/mabi.202000307 ↗
99. O.Khandan A.Famili M. Y.Kahook andM. P.Rao “Titanium‐Based Fenestrated In‐Plane Microneedles for Passive Ocular Drug Delivery ” in2012 Annual International Conference of the IEEE Engineering in Medicine and Biology Society(IEEE 2012) 6572–6575.10.1109/EMBC.2012.6347500 ↗
100. 10.1007/s13346‐016‐0321‐z10.1007/s13346‐016‐0321‐z ↗